What are the important things to pay attention to before taking Besudil mesylate tablets?

Belumosudil mesylate tablets (belumosudil), as an innovative treatment drug, is designed for adult and pediatric patients aged 12 years and above with chronic graft-versus-host disease (cGVHD) who have experienced at least two previous systemic treatments without success. Besudil has demonstrated strong and durable efficacy across the entire spectrum of cGVHD, and is safe and tolerable, allowing patients to adhere to treatment and derive tangible benefits. It is worth mentioning that besudil is the first ROCK2 small molecule inhibitor approved by the FDA. ROCK2 is a signaling pathway that plays a key role in regulating inflammatory responses and fibrosis. By inhibiting this pathway, besudil brings new therapeutic hope to cGVHD patients.

Before deciding to take Besudil, patients must fully communicate with their medical staff and inform them of all their physical conditions. Especially for those patients with kidney or liver problems, it is important to inform the doctor in advance so that the doctor can adjust the treatment plan according to the actual situation. For female patients, if you are pregnant or plan to become pregnant, you must inform your healthcare provider immediately because besudil may cause harm to the fetus. Before starting treatment, medical staff will perform a pregnancy test on female patients who are able to become pregnant to ensure safety. At the same time, women should take effective contraceptive measures during treatment and within 1 week after the last dose. Male patients also need to take contraceptive measures during this period if their female partner may become pregnant.

In addition, female patients who are breastfeeding or planning to breastfeed should also pay special attention because it is unclear whether Besudil will pass into breast milk. Therefore, breastfeeding should be avoided during treatment with besudil and for 1 week after the last dose.

Patients should also tell their healthcare provider about all the medications they are taking, including prescription drugs, over-the-counter drugs, vitamins, and herbal supplements. Because besudil may affect the way other drugs work, and other drugs may also affect the effectiveness of besudil. Therefore, knowing and keeping a list of your medications is crucial to ensuring safe treatment.

During treatment, medical staff will perform blood tests at least once a month to monitor the patient's liver condition. At the same time, patients should also pay attention to observe whether they have adverse reactions such as infection, fatigue, nausea, diarrhea, dyspnea, cough, edema, bleeding, abdominal pain, musculoskeletal pain, headache, and hypertension. If any discomfort occurs, medical staff should be informed promptly so that the doctor can adjust the treatment plan according to the actual situation.

In short, Besudil Mesylate Tablets is an innovative therapeutic drug, which isNew hope for patients with cGVHD. However, before taking it, patients must fully communicate with medical staff to understand their physical condition and medication precautions to ensure the safety and effectiveness of the treatment.

Reference materials:https://www.drugs.com/pro/rezurock.html